The Cervical Cancer Research Network (Gynecologic Cancer InterGroup) roadmap to expand research in low- and middle-income countries
Authors:
Open Access
- 1 May 2021
- journal article
- review article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 31 (5) , 775-778
Abstract
Cervical cancer is a global health problem which disproportionally affects women in low- and middle- income countries. The World Health Organization recently launched its global strategy to eliminate this disease in the next two decades. For those women diagnosed today with cervical cancer better strategies are needed to improve outcome and reduce treatment-related morbidity. Clinical trials are critical to shaping future treatment, and much has been achieved already. However, such opportunities are limited in low resource settings, and the Cervical Cancer Research Network is dedicated to expanding access to new technologies in surgery, radiation, and medical oncology. In this article we review the status of the trials portfolio and outline future objectives, including the launch of a number of research grants for aspiring or established researchers in low- and middle-income settingsKeywords
This publication has 16 references indexed in Scilit:
- Impact of micrometastasis or isolated tumor cells on recurrence and survival in patients with early cervical cancer: SENTICOL TrialInternational Journal of Gynecological Cancer, 2019
- Sentinel lymph node (SLN) concept in cervical cancer: Current limitations and unanswered questionsGynecologic Oncology, 2019
- Advancing clinical research globally: Cervical cancer research network from MexicoGynecologic Oncology Reports, 2018
- Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1–Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 TrialJournal of Clinical Oncology, 2017
- Cervix Cancer Research Network (CCRN)International Journal of Gynecological Cancer, 2016
- Bulky Early-Stage Cervical Cancer (2-4 cm Lesions)International Journal of Gynecological Cancer, 2015
- Global cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2015
- Improved Survival with Bevacizumab in Advanced Cervical CancerNew England Journal of Medicine, 2014
- A phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancerBritish Journal of Cancer, 2013
- Bilateral Negative Sentinel Nodes Accurately Predict Absence of Lymph Node Metastasis in Early Cervical Cancer: Results of the SENTICOL StudyJournal of Clinical Oncology, 2011